Urolithiasis prevalence in the Russian Federation: analysis of trends over a 15-year period
- PMID: 34008087
- DOI: 10.1007/s00345-021-03729-y
Urolithiasis prevalence in the Russian Federation: analysis of trends over a 15-year period
Abstract
Purpose: To conduct a comparative analysis of the prevalence of urolithiasis in the Russian Federation.
Methods: We analysed urolithiasis prevalence and incidence data from 2005 to 2019 (15 years) for the entire population of Russia. Data were provided by the 'Ministry of Health' of the Russian Federation. The prevalence and incidence of urolithiasis were collected and analysed for both adults and children for each region of the Russian Federation over this 15-year period. Statistical analysis was performed using the SPSS Statistics 21 software package (SPSS). Intergroup correlations and differences between samples in the studied parameters were considered significant at p < 0.05.
Results: A total of 656,911 and 889,891 urolithiasis cases were observed in 2005 and 2019, respectively, an increase in urolithiasis prevalence of 35.4% for the study period, with the growth rate that was fairly uniform. The incidence of urolithiasis in the Russian Federation was 176,773 in 2005, while 205,414 new urolithiasis cases were recorded in 2019, with a clear tendency to a rising incidence of urolithiasis, an increase of 16.2% during the study period. The incidence per 100,000 in children remained stable during the entire period of analysis.
Conclusion: The incidence and prevalence of urolithiasis in the adult population steadily increased in all regions of the Russian Federation, while the incidence in children remained stable. The incidence of urolithiasis was associated with an increase in the incidence of diabetes mellitus, obesity and meat consumptions, highlighting the strong association of kidney stone disease with these risk factors.
Keywords: Incidence; Kidney stone; Prevalence; Russian Federation; Urolithiasis.
© 2021. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature.
References
-
- Pak CYC (1998) Kidney stones. Lancet 351:1797–1801. https://doi.org/10.1016/S0140-6736(98)01295-1 - DOI - PubMed
-
- Stamatelou KK, Francis ME, Jones CA, Nyberg Jr LM, Curhan GC. Time trends in reported prevalence of kidney stones in the United States: 1976–1994. Clinical Nephrology – Epidemiology – Clinical Trials 63:1817–1823. https://doi.org/10.1046/j.1523-1755.2003.00917.x
-
- Rukin NJ, Siddiqui ZA, Chedgy ECP, Somani BK (2017) Trends in upper tract stone disease in England: evidence from the hospital episodes statistics database. Urol Int 98:391–396. https://doi.org/10.1159/000449510 - DOI - PubMed
-
- Abrahams HM, Meng MV, Stoller ML (2007) Urinary stone inhibitors. In: Urinary stone disease, pp 157–173. https://doi.org/10.1007/978-1-59259-972-1_9
-
- Morgan MSC, Pearle MS (2016) Medical management of renal stones. BMJ 352:1–12. https://doi.org/10.1136/bmj.i52 - DOI
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
